An update from Collplant Holdings ( ($CLGN) ) is now available. On October 16, 2025, CollPlant Biotechnologies announced the development of a ...
Indian Defence Review on MSN
First-Ever Successful Pig Liver Transplant in a Living Person: A Major Milestone in Medical Science
A groundbreaking pig-to-human liver transplant offers hope for solving the global organ shortage, but major hurdles remain in ...
Science, technology and innovation (STI) ministers and senior officials from G20 member states and invited countries gathered in Tshwane, South Africa, on September 23 for the G20 Research and ...
Despite setbacks and funding cuts — and a quieting of the hype blaring its arrival — multiple CRISPR-based trials are ...
The Hong Kong University of Science and Technology (HKUST) today held its Congregation 2025, conferring Honorary Doctorates ...
Sana Biotechnology, Inc. is working on a gene therapy to cure Type 1 diabetes. Click here to find out why SANA stock is a ...
Federal research funding cuts threaten UC Davis discoveries in health, agriculture and technology that improve lives ...
By implanting key spider DNA sequences into the silkworm genome, Kraig Labs has turned one of nature’s most efficient fiber producers into a biological factory for a biodegradable super fiber five ...
CollPlant Biotechnologies , a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary, non-animal recombinant human collagen (rhCollagen), ...
Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that the U.S. Food and Drug Administration (FDA) has extended its review timeline of the Biologics License Application (BLA) seeking accelerated ...
Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that the U.S. Food and Drug Administration (FDA) has extended its review timeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback